

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of light stimulus involved in sensory perception (GO:0050962) | 8.99185815 |
| 2 | detection of light stimulus involved in visual perception (GO:0050908) | 8.99185815 |
| 3 | Peyers patch development (GO:0048541) | 8.17154884 |
| 4 | mucosal-associated lymphoid tissue development (GO:0048537) | 8.17154884 |
| 5 | regulation of voltage-gated calcium channel activity (GO:1901385) | 7.40136255 |
| 6 | regulation of chromatin binding (GO:0035561) | 5.95281587 |
| 7 | behavioral response to ethanol (GO:0048149) | 5.86563488 |
| 8 | cornea development in camera-type eye (GO:0061303) | 5.64936340 |
| 9 | protein-chromophore linkage (GO:0018298) | 5.60175383 |
| 10 | somite development (GO:0061053) | 5.32227133 |
| 11 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 5.24391161 |
| 12 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 4.91945436 |
| 13 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 4.59542252 |
| 14 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 4.44600435 |
| 15 | seminiferous tubule development (GO:0072520) | 4.18207750 |
| 16 | skeletal muscle tissue regeneration (GO:0043403) | 4.11334276 |
| 17 | cellular ketone body metabolic process (GO:0046950) | 4.05749585 |
| 18 | keratinocyte development (GO:0003334) | 3.96688286 |
| 19 | positive regulation of mRNA catabolic process (GO:0061014) | 3.82240994 |
| 20 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.78523130 |
| 21 | Sertoli cell development (GO:0060009) | 3.74485817 |
| 22 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 3.72016275 |
| 23 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 3.69784743 |
| 24 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.68877310 |
| 25 | regulation of mRNA catabolic process (GO:0061013) | 3.67878625 |
| 26 | serotonin metabolic process (GO:0042428) | 3.65805998 |
| 27 | histone H4-K12 acetylation (GO:0043983) | 3.64292887 |
| 28 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.64237845 |
| 29 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.64237845 |
| 30 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.64237845 |
| 31 | thymus development (GO:0048538) | 3.59549678 |
| 32 | ketone body metabolic process (GO:1902224) | 3.58817970 |
| 33 | histone-serine phosphorylation (GO:0035404) | 3.57909346 |
| 34 | regulation of axon guidance (GO:1902667) | 3.50186871 |
| 35 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.49624758 |
| 36 | negative regulation of axon guidance (GO:1902668) | 3.47593432 |
| 37 | spinal cord association neuron differentiation (GO:0021527) | 3.42889377 |
| 38 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.41076255 |
| 39 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.29883117 |
| 40 | adult walking behavior (GO:0007628) | 3.28725172 |
| 41 | cAMP metabolic process (GO:0046058) | 3.28673630 |
| 42 | photoreceptor cell maintenance (GO:0045494) | 3.28062654 |
| 43 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 3.26093539 |
| 44 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 3.26093539 |
| 45 | regulation of cellular senescence (GO:2000772) | 3.23876211 |
| 46 | behavioral response to nicotine (GO:0035095) | 3.22317357 |
| 47 | regulation of histone phosphorylation (GO:0033127) | 3.20098758 |
| 48 | striated muscle atrophy (GO:0014891) | 3.19332826 |
| 49 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 3.18312872 |
| 50 | primary amino compound metabolic process (GO:1901160) | 3.16629718 |
| 51 | neuronal action potential (GO:0019228) | 3.05184452 |
| 52 | uterus development (GO:0060065) | 3.02968635 |
| 53 | muscle atrophy (GO:0014889) | 3.02668319 |
| 54 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.98795404 |
| 55 | interkinetic nuclear migration (GO:0022027) | 2.95392424 |
| 56 | NLS-bearing protein import into nucleus (GO:0006607) | 2.90885883 |
| 57 | regulation of phospholipid biosynthetic process (GO:0071071) | 2.89933889 |
| 58 | sodium-independent organic anion transport (GO:0043252) | 2.89743803 |
| 59 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 2.89370325 |
| 60 | positive regulation of mRNA metabolic process (GO:1903313) | 2.88424446 |
| 61 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.87492516 |
| 62 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.87492516 |
| 63 | spinal cord motor neuron differentiation (GO:0021522) | 2.86992848 |
| 64 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.84421130 |
| 65 | skeletal muscle adaptation (GO:0043501) | 2.84326163 |
| 66 | response to acidic pH (GO:0010447) | 2.83449422 |
| 67 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.81705741 |
| 68 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.81705741 |
| 69 | G-protein coupled receptor internalization (GO:0002031) | 2.80341539 |
| 70 | regulation of gene silencing by RNA (GO:0060966) | 2.75143464 |
| 71 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.75143464 |
| 72 | regulation of gene silencing by miRNA (GO:0060964) | 2.75143464 |
| 73 | neuromuscular junction development (GO:0007528) | 2.72930867 |
| 74 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.69030706 |
| 75 | ventricular septum development (GO:0003281) | 2.68883162 |
| 76 | determination of adult lifespan (GO:0008340) | 2.68809010 |
| 77 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.67447989 |
| 78 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.67447989 |
| 79 | phospholipid catabolic process (GO:0009395) | 2.67313560 |
| 80 | behavioral response to cocaine (GO:0048148) | 2.65268939 |
| 81 | activated T cell proliferation (GO:0050798) | 2.64687013 |
| 82 | adipose tissue development (GO:0060612) | 2.64389920 |
| 83 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.63524724 |
| 84 | regulation of neurotransmitter uptake (GO:0051580) | 2.63086434 |
| 85 | regulation of DNA endoreduplication (GO:0032875) | 2.59075454 |
| 86 | synaptic transmission, glutamatergic (GO:0035249) | 2.58322620 |
| 87 | neural tube formation (GO:0001841) | 2.56305973 |
| 88 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.55939103 |
| 89 | muscle fiber development (GO:0048747) | 2.55424728 |
| 90 | Golgi to endosome transport (GO:0006895) | 2.51897440 |
| 91 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.48854010 |
| 92 | cardiac septum development (GO:0003279) | 2.48157928 |
| 93 | positive regulation of mRNA 3-end processing (GO:0031442) | 2.48010051 |
| 94 | male meiosis (GO:0007140) | 2.47770582 |
| 95 | detection of molecule of bacterial origin (GO:0032490) | 2.46582089 |
| 96 | detection of chemical stimulus involved in sensory perception of smell (GO:0050911) | 2.46476708 |
| 97 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.44250486 |
| 98 | endosome to melanosome transport (GO:0035646) | 2.44068364 |
| 99 | neuronal action potential propagation (GO:0019227) | 12.3336422 |
| 100 | gamma-aminobutyric acid transport (GO:0015812) | 10.6252484 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 7.22882102 |
| 2 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.79052546 |
| 3 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.07583840 |
| 4 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.05535968 |
| 5 | VDR_22108803_ChIP-Seq_LS180_Human | 2.94767611 |
| 6 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.58832969 |
| 7 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.58786319 |
| 8 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.56242948 |
| 9 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.37410068 |
| 10 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.36455610 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.32186163 |
| 12 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.25648097 |
| 13 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.25357230 |
| 14 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.20249535 |
| 15 | EWS_26573619_Chip-Seq_HEK293_Human | 2.18364072 |
| 16 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.13567317 |
| 17 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.00749068 |
| 18 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.96248419 |
| 19 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.93211905 |
| 20 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.92120398 |
| 21 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.89457474 |
| 22 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.85130235 |
| 23 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.81852950 |
| 24 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.76454411 |
| 25 | TP53_16413492_ChIP-PET_HCT116_Human | 1.72908524 |
| 26 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.71583256 |
| 27 | STAT3_23295773_ChIP-Seq_U87_Human | 1.67672100 |
| 28 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.65543294 |
| 29 | GATA1_22025678_ChIP-Seq_K562_Human | 1.62892634 |
| 30 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.62328897 |
| 31 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.60187310 |
| 32 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.59182211 |
| 33 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.57618585 |
| 34 | AR_25329375_ChIP-Seq_VCAP_Human | 1.56779342 |
| 35 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.56216200 |
| 36 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.56216200 |
| 37 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.54514913 |
| 38 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.50817989 |
| 39 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.44660487 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.42975346 |
| 41 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.42765438 |
| 42 | P300_19829295_ChIP-Seq_ESCs_Human | 1.41822622 |
| 43 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.40658831 |
| 44 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.36729288 |
| 45 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.36343544 |
| 46 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.35741841 |
| 47 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.34936373 |
| 48 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.33898363 |
| 49 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.30779945 |
| 50 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28647531 |
| 51 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.27066518 |
| 52 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.26788915 |
| 53 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.26248408 |
| 54 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.23528662 |
| 55 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.21267846 |
| 56 | KDM2B_26808549_Chip-Seq_REH_Human | 1.19751726 |
| 57 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18475362 |
| 58 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.17432521 |
| 59 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.17393493 |
| 60 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16753062 |
| 61 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.16512058 |
| 62 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.14780437 |
| 63 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.14278425 |
| 64 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.12666747 |
| 65 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.11465682 |
| 66 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.11189515 |
| 67 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.10067492 |
| 68 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.09928290 |
| 69 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.08574423 |
| 70 | TCF4_23295773_ChIP-Seq_U87_Human | 1.06500867 |
| 71 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.06117139 |
| 72 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.05069980 |
| 73 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.04853559 |
| 74 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.04394748 |
| 75 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.04394748 |
| 76 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.03973395 |
| 77 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.03769806 |
| 78 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03416900 |
| 79 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.02250089 |
| 80 | JUN_21703547_ChIP-Seq_K562_Human | 1.02040729 |
| 81 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.01473880 |
| 82 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.01062139 |
| 83 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.01062139 |
| 84 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.00985005 |
| 85 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.99296714 |
| 86 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.99175470 |
| 87 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.98583419 |
| 88 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.96474270 |
| 89 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.96165986 |
| 90 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.96143898 |
| 91 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.95184825 |
| 92 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.94437853 |
| 93 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.94166250 |
| 94 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.93900224 |
| 95 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.93342678 |
| 96 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.93342678 |
| 97 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92738061 |
| 98 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.92502931 |
| 99 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.92341456 |
| 100 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91716236 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 5.34331826 |
| 2 | MP0000569_abnormal_digit_pigmentation | 4.19955186 |
| 3 | MP0003880_abnormal_central_pattern | 4.05911233 |
| 4 | MP0000372_irregular_coat_pigmentation | 3.65847474 |
| 5 | MP0002102_abnormal_ear_morphology | 3.36662962 |
| 6 | MP0008057_abnormal_DNA_replication | 3.16756581 |
| 7 | MP0000631_abnormal_neuroendocrine_gland | 3.01808831 |
| 8 | MP0005645_abnormal_hypothalamus_physiol | 3.01516926 |
| 9 | MP0003195_calcinosis | 2.78907366 |
| 10 | MP0005423_abnormal_somatic_nervous | 2.76820212 |
| 11 | MP0008877_abnormal_DNA_methylation | 2.59936401 |
| 12 | MP0003315_abnormal_perineum_morphology | 2.55836025 |
| 13 | MP0002938_white_spotting | 2.37907855 |
| 14 | MP0003724_increased_susceptibility_to | 2.33484915 |
| 15 | MP0009745_abnormal_behavioral_response | 2.28151604 |
| 16 | MP0005671_abnormal_response_to | 2.22220348 |
| 17 | MP0005187_abnormal_penis_morphology | 2.12169740 |
| 18 | MP0005551_abnormal_eye_electrophysiolog | 2.10726984 |
| 19 | MP0001542_abnormal_bone_strength | 1.92842471 |
| 20 | MP0009046_muscle_twitch | 1.91089377 |
| 21 | MP0005647_abnormal_sex_gland | 1.90104726 |
| 22 | MP0003938_abnormal_ear_development | 1.88701233 |
| 23 | MP0005389_reproductive_system_phenotype | 1.77264881 |
| 24 | MP0003866_abnormal_defecation | 1.76668145 |
| 25 | MP0001919_abnormal_reproductive_system | 1.66363691 |
| 26 | MP0001545_abnormal_hematopoietic_system | 1.65326493 |
| 27 | MP0005397_hematopoietic_system_phenotyp | 1.65326493 |
| 28 | MP0002272_abnormal_nervous_system | 1.55676452 |
| 29 | MP0004147_increased_porphyrin_level | 1.52895491 |
| 30 | MP0003890_abnormal_embryonic-extraembry | 1.50906251 |
| 31 | MP0001486_abnormal_startle_reflex | 1.49017712 |
| 32 | MP0003119_abnormal_digestive_system | 1.46661250 |
| 33 | MP0002736_abnormal_nociception_after | 1.42383227 |
| 34 | MP0002572_abnormal_emotion/affect_behav | 1.40473765 |
| 35 | MP0004742_abnormal_vestibular_system | 1.39144663 |
| 36 | MP0004924_abnormal_behavior | 1.38459150 |
| 37 | MP0005386_behavior/neurological_phenoty | 1.38459150 |
| 38 | MP0002277_abnormal_respiratory_mucosa | 1.34669190 |
| 39 | MP0003878_abnormal_ear_physiology | 1.34051196 |
| 40 | MP0005377_hearing/vestibular/ear_phenot | 1.34051196 |
| 41 | MP0001968_abnormal_touch/_nociception | 1.33879149 |
| 42 | MP0008789_abnormal_olfactory_epithelium | 1.28135732 |
| 43 | MP0003937_abnormal_limbs/digits/tail_de | 1.26920075 |
| 44 | MP0002734_abnormal_mechanical_nocicepti | 1.25743248 |
| 45 | MP0009840_abnormal_foam_cell | 1.24941118 |
| 46 | MP0002067_abnormal_sensory_capabilities | 1.24820468 |
| 47 | MP0002160_abnormal_reproductive_system | 1.20719153 |
| 48 | MP0005408_hypopigmentation | 1.20341842 |
| 49 | MP0002932_abnormal_joint_morphology | 1.19684169 |
| 50 | MP0003959_abnormal_lean_body | 1.17491832 |
| 51 | MP0008875_abnormal_xenobiotic_pharmacok | 1.17001244 |
| 52 | MP0005174_abnormal_tail_pigmentation | 1.16037469 |
| 53 | MP0000750_abnormal_muscle_regeneration | 1.13061888 |
| 54 | MP0002733_abnormal_thermal_nociception | 1.09173534 |
| 55 | MP0002138_abnormal_hepatobiliary_system | 1.03561400 |
| 56 | MP0003950_abnormal_plasma_membrane | 1.03559820 |
| 57 | MP0008961_abnormal_basal_metabolism | 1.01904564 |
| 58 | MP0001293_anophthalmia | 1.01652788 |
| 59 | MP0004484_altered_response_of | 1.00098893 |
| 60 | MP0003828_pulmonary_edema | 0.98521631 |
| 61 | MP0003221_abnormal_cardiomyocyte_apopto | 0.96963316 |
| 62 | MP0002064_seizures | 0.95160471 |
| 63 | MP0001970_abnormal_pain_threshold | 0.94214228 |
| 64 | MP0009764_decreased_sensitivity_to | 0.93705426 |
| 65 | MP0003787_abnormal_imprinting | 0.93089911 |
| 66 | MP0003635_abnormal_synaptic_transmissio | 0.91677614 |
| 67 | MP0002109_abnormal_limb_morphology | 0.91472129 |
| 68 | MP0001119_abnormal_female_reproductive | 0.88190999 |
| 69 | MP0005266_abnormal_metabolism | 0.86684137 |
| 70 | MP0003698_abnormal_male_reproductive | 0.84892068 |
| 71 | MP0002152_abnormal_brain_morphology | 0.84536359 |
| 72 | MP0000427_abnormal_hair_cycle | 0.84258106 |
| 73 | MP0002752_abnormal_somatic_nervous | 0.83498827 |
| 74 | MP0002557_abnormal_social/conspecific_i | 0.83440915 |
| 75 | MP0002735_abnormal_chemical_nociception | 0.83092911 |
| 76 | MP0002822_catalepsy | 0.82731824 |
| 77 | MP0000639_abnormal_adrenal_gland | 0.78661241 |
| 78 | MP0002234_abnormal_pharynx_morphology | 0.77778869 |
| 79 | MP0001440_abnormal_grooming_behavior | 0.77748059 |
| 80 | MP0004270_analgesia | 0.77021700 |
| 81 | MP0003121_genomic_imprinting | 0.76994067 |
| 82 | MP0000003_abnormal_adipose_tissue | 0.75010795 |
| 83 | MP0005394_taste/olfaction_phenotype | 0.72715453 |
| 84 | MP0005499_abnormal_olfactory_system | 0.72715453 |
| 85 | MP0004885_abnormal_endolymph | 0.69675718 |
| 86 | MP0001929_abnormal_gametogenesis | 0.69578937 |
| 87 | MP0000653_abnormal_sex_gland | 0.69129783 |
| 88 | MP0001324_abnormal_eye_pigmentation | 0.68008373 |
| 89 | MP0003693_abnormal_embryo_hatching | 0.67845628 |
| 90 | MP0003303_peritoneal_inflammation | 0.67603684 |
| 91 | MP0003935_abnormal_craniofacial_develop | 0.65390503 |
| 92 | MP0001485_abnormal_pinna_reflex | 0.64698882 |
| 93 | MP0005167_abnormal_blood-brain_barrier | 0.63957932 |
| 94 | MP0001286_abnormal_eye_development | 0.61968947 |
| 95 | MP0003115_abnormal_respiratory_system | 0.59828119 |
| 96 | MP0000955_abnormal_spinal_cord | 0.58845746 |
| 97 | MP0003646_muscle_fatigue | 0.58179360 |
| 98 | MP0003638_abnormal_response/metabolism_ | 0.58030015 |
| 99 | MP0010030_abnormal_orbit_morphology | 0.57890504 |
| 100 | MP0003045_fibrosis | 0.57428976 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bilateral sensorineural hearing impairment (HP:0008619) | 9.64337198 |
| 2 | Hyperventilation (HP:0002883) | 5.84231541 |
| 3 | Gaze-evoked nystagmus (HP:0000640) | 5.54965918 |
| 4 | Tinnitus (HP:0000360) | 5.14962783 |
| 5 | Abnormality of dentin (HP:0010299) | 4.37425143 |
| 6 | Gonadotropin excess (HP:0000837) | 4.34781390 |
| 7 | Tubular atrophy (HP:0000092) | 4.32758310 |
| 8 | Inappropriate behavior (HP:0000719) | 4.30542261 |
| 9 | Febrile seizures (HP:0002373) | 3.99784226 |
| 10 | Acanthocytosis (HP:0001927) | 3.79349455 |
| 11 | Tubulointerstitial fibrosis (HP:0005576) | 3.71230404 |
| 12 | Enlarged penis (HP:0000040) | 3.68532184 |
| 13 | Atonic seizures (HP:0010819) | 3.64506343 |
| 14 | Dyskinesia (HP:0100660) | 3.38586355 |
| 15 | Polydipsia (HP:0001959) | 3.35751761 |
| 16 | Abnormal drinking behavior (HP:0030082) | 3.35751761 |
| 17 | Small hand (HP:0200055) | 3.32569477 |
| 18 | Protruding tongue (HP:0010808) | 3.28433767 |
| 19 | Drooling (HP:0002307) | 3.22313356 |
| 20 | Abnormality of midbrain morphology (HP:0002418) | 3.19921564 |
| 21 | Molar tooth sign on MRI (HP:0002419) | 3.19921564 |
| 22 | Fair hair (HP:0002286) | 3.15675391 |
| 23 | Birth length less than 3rd percentile (HP:0003561) | 3.08810423 |
| 24 | Acute lymphatic leukemia (HP:0006721) | 3.07826375 |
| 25 | Excessive salivation (HP:0003781) | 3.05805201 |
| 26 | Generalized myoclonic seizures (HP:0002123) | 3.05352506 |
| 27 | Disinhibition (HP:0000734) | 3.03628613 |
| 28 | Type 2 muscle fiber atrophy (HP:0003554) | 3.03359594 |
| 29 | Nephronophthisis (HP:0000090) | 2.87508325 |
| 30 | Curly hair (HP:0002212) | 2.74665949 |
| 31 | Abnormality of the renal cortex (HP:0011035) | 2.70885440 |
| 32 | Abnormality of the dental pulp (HP:0006479) | 2.69954665 |
| 33 | Absent speech (HP:0001344) | 2.68829742 |
| 34 | Abnormality of the renal medulla (HP:0100957) | 2.66476180 |
| 35 | Polyuria (HP:0000103) | 2.61449383 |
| 36 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.58640587 |
| 37 | Absent/shortened dynein arms (HP:0200106) | 2.58640587 |
| 38 | Focal seizures (HP:0007359) | 2.57895069 |
| 39 | Tubulointerstitial abnormality (HP:0001969) | 2.52267835 |
| 40 | Pancreatic cysts (HP:0001737) | 2.49586222 |
| 41 | Concave nail (HP:0001598) | 2.46996566 |
| 42 | Flat occiput (HP:0005469) | 2.45355745 |
| 43 | Thickened helices (HP:0000391) | 2.44515315 |
| 44 | Broad-based gait (HP:0002136) | 2.43795422 |
| 45 | Choroideremia (HP:0001139) | 2.43251065 |
| 46 | Muscle fiber atrophy (HP:0100295) | 2.40296813 |
| 47 | Abnormality of the ileum (HP:0001549) | 2.34164374 |
| 48 | Acute hepatic failure (HP:0006554) | 2.29306055 |
| 49 | Hypoplastic pelvis (HP:0008839) | 2.29107860 |
| 50 | Generalized hypopigmentation of hair (HP:0011358) | 2.28918626 |
| 51 | Medial flaring of the eyebrow (HP:0010747) | 2.23291965 |
| 52 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.23247886 |
| 53 | Decreased central vision (HP:0007663) | 2.22724419 |
| 54 | Attenuation of retinal blood vessels (HP:0007843) | 2.21873360 |
| 55 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.19305897 |
| 56 | Stereotypic behavior (HP:0000733) | 2.18433713 |
| 57 | Clumsiness (HP:0002312) | 2.16809743 |
| 58 | Focal motor seizures (HP:0011153) | 2.16314928 |
| 59 | Volvulus (HP:0002580) | 2.14681048 |
| 60 | Asplenia (HP:0001746) | 2.10185074 |
| 61 | Nonprogressive disorder (HP:0003680) | 2.09321668 |
| 62 | Bulbous nose (HP:0000414) | 2.08092582 |
| 63 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.07686483 |
| 64 | Optic neuritis (HP:0100653) | 2.05953970 |
| 65 | Retrobulbar optic neuritis (HP:0100654) | 2.05953970 |
| 66 | Orchitis (HP:0100796) | 2.04016804 |
| 67 | Meckel diverticulum (HP:0002245) | 2.03036707 |
| 68 | Abnormality of salivation (HP:0100755) | 2.02828504 |
| 69 | Abnormal urine output (HP:0012590) | 2.02780282 |
| 70 | Hemiparesis (HP:0001269) | 2.00977983 |
| 71 | Abnormality of placental membranes (HP:0011409) | 1.99368868 |
| 72 | Amniotic constriction ring (HP:0009775) | 1.99368868 |
| 73 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.96973395 |
| 74 | Severe muscular hypotonia (HP:0006829) | 1.94444697 |
| 75 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.92225486 |
| 76 | Genital tract atresia (HP:0001827) | 1.89852247 |
| 77 | Aplasia cutis congenita (HP:0001057) | 1.88693064 |
| 78 | Widely spaced teeth (HP:0000687) | 1.88662830 |
| 79 | Partial agenesis of the corpus callosum (HP:0001338) | 1.88152698 |
| 80 | Supernumerary spleens (HP:0009799) | 1.85954918 |
| 81 | Vaginal atresia (HP:0000148) | 1.84852568 |
| 82 | Inability to walk (HP:0002540) | 1.82626417 |
| 83 | Exotropia (HP:0000577) | 1.81108381 |
| 84 | Pancreatic fibrosis (HP:0100732) | 1.80581380 |
| 85 | Midline defect of the nose (HP:0004122) | 1.78585424 |
| 86 | Abnormality of the neuromuscular junction (HP:0003398) | 1.77530010 |
| 87 | Fatigable weakness (HP:0003473) | 1.77530010 |
| 88 | Abnormality of renal excretion (HP:0011036) | 1.77274793 |
| 89 | Self-mutilation (HP:0000742) | 1.77163079 |
| 90 | Abnormality of the carotid arteries (HP:0005344) | 1.76829810 |
| 91 | Cystic hygroma (HP:0000476) | 1.76132986 |
| 92 | Abnormality of the preputium (HP:0100587) | 1.73655930 |
| 93 | Absence seizures (HP:0002121) | 1.71267598 |
| 94 | Osteomalacia (HP:0002749) | 1.70835054 |
| 95 | Palpebral edema (HP:0100540) | 1.70624220 |
| 96 | Septo-optic dysplasia (HP:0100842) | 1.69970341 |
| 97 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.63403798 |
| 98 | Status epilepticus (HP:0002133) | 1.63299098 |
| 99 | Aplasia of the musculature (HP:0100854) | 1.62633691 |
| 100 | Patellar aplasia (HP:0006443) | 1.59889700 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K4 | 4.67162021 |
| 2 | MAP3K6 | 4.42854167 |
| 3 | MAP3K9 | 4.32193177 |
| 4 | ACVR1B | 4.19741674 |
| 5 | TNIK | 3.71020799 |
| 6 | MKNK2 | 3.31717244 |
| 7 | MUSK | 2.94263682 |
| 8 | BRSK2 | 2.89329871 |
| 9 | CASK | 2.87080097 |
| 10 | PTK2B | 2.55284266 |
| 11 | MAP2K7 | 2.46430145 |
| 12 | BMPR1B | 2.03297020 |
| 13 | FRK | 1.96995055 |
| 14 | PLK4 | 1.83365350 |
| 15 | MKNK1 | 1.83067602 |
| 16 | MAP2K4 | 1.78858699 |
| 17 | WNK3 | 1.66044976 |
| 18 | KSR2 | 1.63614505 |
| 19 | BRAF | 1.61972029 |
| 20 | IRAK1 | 1.60021944 |
| 21 | EPHA4 | 1.58260904 |
| 22 | SIK2 | 1.49690208 |
| 23 | DYRK3 | 1.48102854 |
| 24 | RAF1 | 1.46684489 |
| 25 | ERN1 | 1.42413312 |
| 26 | NTRK2 | 1.41534601 |
| 27 | NUAK1 | 1.40432264 |
| 28 | MARK3 | 1.33223370 |
| 29 | MARK1 | 1.13929457 |
| 30 | ADRBK1 | 1.12893071 |
| 31 | ARAF | 1.11912655 |
| 32 | INSRR | 1.02718012 |
| 33 | AKT3 | 1.02276613 |
| 34 | SGK2 | 0.97336149 |
| 35 | TGFBR1 | 0.90573835 |
| 36 | NEK2 | 0.90377695 |
| 37 | IRAK4 | 0.88461046 |
| 38 | NLK | 0.87094890 |
| 39 | MAP3K5 | 0.86416695 |
| 40 | MAP3K13 | 0.84132717 |
| 41 | PKN1 | 0.82257238 |
| 42 | GRK1 | 0.81710814 |
| 43 | WNK4 | 0.78749029 |
| 44 | ERBB3 | 0.78108792 |
| 45 | PIK3CA | 0.77866216 |
| 46 | TLK1 | 0.76780553 |
| 47 | MAPK13 | 0.75969451 |
| 48 | ADRBK2 | 0.74836158 |
| 49 | MAP2K1 | 0.74349375 |
| 50 | PAK3 | 0.71386847 |
| 51 | OXSR1 | 0.70675539 |
| 52 | MAP2K3 | 0.69523125 |
| 53 | WNK1 | 0.67129009 |
| 54 | PRKCQ | 0.64230372 |
| 55 | STK3 | 0.60778350 |
| 56 | TAF1 | 0.60471571 |
| 57 | RPS6KA4 | 0.59454598 |
| 58 | PRKCG | 0.58679725 |
| 59 | STK38 | 0.55997666 |
| 60 | TNK2 | 0.55064725 |
| 61 | CHEK2 | 0.53692391 |
| 62 | TGFBR2 | 0.53260680 |
| 63 | PRKAA2 | 0.52542060 |
| 64 | SGK223 | 0.52465729 |
| 65 | SGK494 | 0.52465729 |
| 66 | DYRK1A | 0.51396501 |
| 67 | NEK9 | 0.51356627 |
| 68 | MOS | 0.49636447 |
| 69 | RET | 0.48562253 |
| 70 | BRSK1 | 0.48463917 |
| 71 | KSR1 | 0.46348577 |
| 72 | PLK3 | 0.46030483 |
| 73 | SGK3 | 0.46003564 |
| 74 | CAMK1D | 0.44909220 |
| 75 | STK11 | 0.43287675 |
| 76 | TAOK1 | 0.40812875 |
| 77 | STK39 | 0.39940463 |
| 78 | FGR | 0.36347540 |
| 79 | FGFR1 | 0.34774517 |
| 80 | MAP4K2 | 0.33451096 |
| 81 | PRKCE | 0.33325033 |
| 82 | MAP3K2 | 0.30216310 |
| 83 | CSNK1D | 0.30144525 |
| 84 | PLK1 | 0.29386154 |
| 85 | LYN | 0.28985488 |
| 86 | RPS6KA5 | 0.28626409 |
| 87 | PAK6 | 0.28416637 |
| 88 | MINK1 | 0.27750952 |
| 89 | MELK | 0.27635287 |
| 90 | BLK | 0.26984611 |
| 91 | DMPK | 0.26234623 |
| 92 | VRK1 | 0.26067473 |
| 93 | IRAK2 | 0.25191024 |
| 94 | DYRK2 | 0.25097721 |
| 95 | CAMK4 | 0.23420493 |
| 96 | STK38L | 0.23321995 |
| 97 | CAMK2A | 0.23018558 |
| 98 | STK10 | 0.21896233 |
| 99 | MAP3K8 | 0.20636306 |
| 100 | STK24 | 0.20077295 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 4.25361744 |
| 2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 4.13973003 |
| 3 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 3.59653076 |
| 4 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.71252494 |
| 5 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 2.56150184 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.37149541 |
| 7 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.13996104 |
| 8 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.01384039 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.00048538 |
| 10 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.94623914 |
| 11 | Homologous recombination_Homo sapiens_hsa03440 | 1.86538418 |
| 12 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.84334416 |
| 13 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.83615438 |
| 14 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.78880076 |
| 15 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.71501907 |
| 16 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.69302832 |
| 17 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.67570042 |
| 18 | Long-term depression_Homo sapiens_hsa04730 | 1.46491323 |
| 19 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.44595259 |
| 20 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.37873595 |
| 21 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.33875777 |
| 22 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.33694299 |
| 23 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.26733287 |
| 24 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.21615141 |
| 25 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.20919071 |
| 26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.18772797 |
| 27 | MAPK signaling pathway_Homo sapiens_hsa04010 | 1.18409606 |
| 28 | Nicotine addiction_Homo sapiens_hsa05033 | 1.17597507 |
| 29 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.15828388 |
| 30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.15746712 |
| 31 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.15624854 |
| 32 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.14541742 |
| 33 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.14064621 |
| 34 | Melanogenesis_Homo sapiens_hsa04916 | 1.11355455 |
| 35 | Cocaine addiction_Homo sapiens_hsa05030 | 1.08241827 |
| 36 | Taste transduction_Homo sapiens_hsa04742 | 1.07476080 |
| 37 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.06460982 |
| 38 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.05508685 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.04999542 |
| 40 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.94905203 |
| 41 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.94031877 |
| 42 | Basal transcription factors_Homo sapiens_hsa03022 | 0.92641507 |
| 43 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.90036446 |
| 44 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.88181383 |
| 45 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.88101363 |
| 46 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.87752883 |
| 47 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.86051773 |
| 48 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.84339702 |
| 49 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.82394781 |
| 50 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.80398202 |
| 51 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.78628589 |
| 52 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.77255019 |
| 53 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.76733158 |
| 54 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.75931212 |
| 55 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.75874145 |
| 56 | Melanoma_Homo sapiens_hsa05218 | 0.74857456 |
| 57 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.73971832 |
| 58 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.73214540 |
| 59 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.73132226 |
| 60 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.71290523 |
| 61 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.65553071 |
| 62 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.64776311 |
| 63 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.64327497 |
| 64 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.63687788 |
| 65 | Morphine addiction_Homo sapiens_hsa05032 | 0.62787119 |
| 66 | Phototransduction_Homo sapiens_hsa04744 | 0.62634926 |
| 67 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.60788771 |
| 68 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.58786385 |
| 69 | Platelet activation_Homo sapiens_hsa04611 | 0.57192976 |
| 70 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.57156363 |
| 71 | Axon guidance_Homo sapiens_hsa04360 | 0.56661402 |
| 72 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.55933032 |
| 73 | Gap junction_Homo sapiens_hsa04540 | 0.55612478 |
| 74 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.54077729 |
| 75 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.52924218 |
| 76 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.50695779 |
| 77 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50614332 |
| 78 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.50209612 |
| 79 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.49227366 |
| 80 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.48794173 |
| 81 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.47598759 |
| 82 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.46836467 |
| 83 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.45713647 |
| 84 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43181741 |
| 85 | Legionellosis_Homo sapiens_hsa05134 | 0.42111151 |
| 86 | Peroxisome_Homo sapiens_hsa04146 | 0.39943606 |
| 87 | Alcoholism_Homo sapiens_hsa05034 | 0.39607737 |
| 88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38816739 |
| 89 | Bladder cancer_Homo sapiens_hsa05219 | 0.37598552 |
| 90 | RNA degradation_Homo sapiens_hsa03018 | 0.36429486 |
| 91 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.36399890 |
| 92 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.35096327 |
| 93 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.35016885 |
| 94 | Malaria_Homo sapiens_hsa05144 | 0.34828575 |
| 95 | Pathways in cancer_Homo sapiens_hsa05200 | 0.34813673 |
| 96 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.34295383 |
| 97 | Prostate cancer_Homo sapiens_hsa05215 | 0.33617285 |
| 98 | Circadian entrainment_Homo sapiens_hsa04713 | 0.32033532 |
| 99 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.31790730 |
| 100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.30562742 |

